Fenestrated AAA Endovascular Graft Post-Approval Study

Evaluation of the Long-term Safety and Performance of the Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Post-Approval Study

This post-market study is approved by the US FDA to evaluate the long-term safety and performance of the Zenith® Fenestrated AAA Endovascular Graft.

Inclusion Criteria:

• abdominal aortic and aortoiliac aneursyms with a diameter greater than or equal to 5 cm
• aortic or aortoiliac aneurysm with a history of growth greater than or equal to 0.5 cm per year, or clinical indication for AAA repair

Exclusion Criteria:

• proximal neck less than 4mm or greater than or equal to 15 mm in length unless otherwise compromised to preclude seal
• renal artery stenosis greater than 50 percent